Skip to content
InsideEdge
Investors / filer profile

No completed buy history yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$1.74M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$5.7M$11.4M2025 · bought $0 · sold $1.3M20252026 · bought $0 · sold $11.4M2026
Total +$0.0000 bought · $12.72M sold

All filings on record

Every Form 4 transaction we track for this filer

MLYSSell
2026-06-17 · Mineralys Therapeutics, Inc.
$114.6K
MLYSExercise
2026-06-17 · Mineralys Therapeutics, Inc.
$6.4K
MLYSExercise
2026-06-17 · Mineralys Therapeutics, Inc.
$59.4K
MLYSSell
2026-06-15 · Mineralys Therapeutics, Inc.
$235.5K
MLYSExercise
2026-06-15 · Mineralys Therapeutics, Inc.
$36.1K
MLYSSell
2026-06-12 · Mineralys Therapeutics, Inc.
$151.9K
MLYSExercise
2026-06-12 · Mineralys Therapeutics, Inc.
$6.9K
MLYSSell
2026-06-10 · Mineralys Therapeutics, Inc.
$54.3K
MLYSExercise
2026-06-10 · Mineralys Therapeutics, Inc.
$34.7K
MLYSSell
2026-05-18 · Mineralys Therapeutics, Inc.
$11.5K
MLYSExercise
2026-05-18 · Mineralys Therapeutics, Inc.
$6.4K
MLYSGrant
2026-02-19 · Mineralys Therapeutics, Inc.
38,400
MLYSSell
2026-02-17 · Mineralys Therapeutics, Inc.
$11.5K
MLYSExercise
2026-02-17 · Mineralys Therapeutics, Inc.
$6.4K
MLYSSell
2026-02-13 · Mineralys Therapeutics, Inc.
$175.1K
MLYSSell
2026-02-13 · Mineralys Therapeutics, Inc.
$113.9K
MLYSExercise
2026-02-13 · Mineralys Therapeutics, Inc.
$59.4K
MLYSSell
2026-02-13 · Mineralys Therapeutics, Inc.
$96.8K
MLYSExercise
2026-02-13 · Mineralys Therapeutics, Inc.
$36.1K
MLYSSell
2026-02-12 · Mineralys Therapeutics, Inc.
$15.4K
MLYSSell
2026-02-12 · Mineralys Therapeutics, Inc.
$168.6K
MLYSExercise
2026-02-12 · Mineralys Therapeutics, Inc.
$6.9K
MLYSSell
2026-02-09 · Mineralys Therapeutics, Inc.
$65.6K
MLYSExercise
2026-02-09 · Mineralys Therapeutics, Inc.
$34.7K
MLYSSell
2026-01-20 · Mineralys Therapeutics, Inc.
$13.4K

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.